Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024		Sep. 30, 2023
Operating activities
Net income	$ 29,125,711		$ 29,312,725
Adjustments to reconcile net income to net cash provided by operating activities:
Accretion of deferred loan origination fees and other discounts	(1,311,760)	[1]	(1,989,374)	[2]
Paid-in-kind interest	(7,688,284)	[1]	(6,343,749)	[2]
(Decrease) increase in provision for current expected credit losses	(884,789)		1,193,880
Change in unrealized gain on debt securities, at fair value	75,604		(112,767)
Realized gain on debt securities, at fair value	(72,428)
Amortization of debt issuance costs	262,361		405,778
Stock based compensation	2,213,150		942,605
Changes in operating assets and liabilities:
Interest receivable	519,779		(1,022,490)
Other receivables and assets, net	(58,034)		(146,364)
Interest reserve	1,505,998		(1,369,929)
Related party payables	(480,987)		271,268
Related party receivables	(1,364,396)		(3,284,900)
Purchase of debt securities, at fair value			(3,356,573)
Proceeds from the redemption of debt securities, at fair value	839,094
Management and incentive fees payable	(1,574,659)		(1,694,213)
Accounts payable and accrued expenses	225,454		106,839
Net cash provided by operating activities	21,331,814		12,912,736
Cash flows from investing activities
Issuance of and fundings of loans held for investment	(75,230,855)		(67,422,648)
Principal repayment of loans held for investment	64,198,999		62,837,108
Proceeds from sale of loans	13,000,000		13,399,712
Net cash provided by investing activities	1,968,144		8,814,172
Cash flows from financing activities
Proceeds from sale of common stock	20,796,750		7,222,363
Proceeds from borrowings on revolving loan	73,500,000		64,000,000
Repayment of borrowings on revolving loan	(85,500,000)		(59,000,000)
Dividends paid to common shareholders	(32,364,650)		(30,566,088)
Payment of debt issuance costs	(113,129)		(112,279)
Payment of offering costs	(756,536)		(284,574)
Net cash used in financing activities	(24,437,565)		(18,740,578)
Net (decrease) increase in cash and cash equivalents	(1,137,607)		2,986,330
Cash and cash equivalents, beginning of period	7,898,040		5,715,827
Cash and cash equivalents, end of period	6,760,433		8,702,157
Supplemental disclosure of non-cash financing and investing activities
Interest reserve withheld from funding of loans	4,164,021		1,007,910
OID withheld from funding of loans held for investment	820,335		1,676,017
Dividends declared and not yet paid	9,267,714		8,568,252
Transfer of loans held for investment to loans held for sale	19,000,000		13,399,712
Supplemental information:
Interest paid during the period	$ 5,338,916		$ 3,530,521

[1] The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable.

[2] The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable.